study protocol Press Release

Title Picture
10/03/2018 - 22:34
FDA approves Roches Hemlibra for haemophilia A without factor VIII inhibitors
Rocheusa's picture
Rocheusa
10/03/2018 - 19:01
FDA Approves Genentechs Hemlibra (Emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors
Genentech's picture
Genentech
09/25/2018 - 06:51
Roches Tecentriq in combination with chemotherapy helped people live significantly longer as an initial treatment for people with extensive-stage small cell lung cancer
Rocheusa's picture
Rocheusa
09/25/2018 - 03:43
Genentechs TECENTRIQ in Combination With Chemotherapy Helped People Live Significantly Longer as an Initial Treatment for People With Extensive-Stage Small Cell Lung Cancer
Genentech's picture
Genentech
09/24/2018 - 23:59
Results of LUME-Meso trial in malignant pleural mesothelioma presented at the 19 th World Conference on Lung Cancer (WCLC 2018)
Boehringer-Ingelheim's picture
Boehringer-Ingelheim
09/24/2018 - 18:02
Roches Tecentriq in combination with pemetrexed and platinum-based chemotherapy reduced the risk of disease worsening or death in a type of previously untreated advanced lung cancer
Rocheusa's picture
Rocheusa
09/24/2018 - 03:10
Genentechs TECENTRIQ in Combination With Pemetrexed and Platinum-Based Chemotherapy Reduced the Risk of Disease Worsening or Death in a Type of Previously Untreated Advanced Lung Cancer
Genentech's picture
Genentech
08/25/2018 - 13:49
Novartis announces new data that show Entresto (sacubitril/valsartan) can be initiated early & safely in hospitalized patients after an acute heart failure episode
Novartis's picture
Novartis
08/08/2018 - 23:47
Utilizing Technology to Benefit Diabetes Clinical Trials - Pharmiweb
CRF Health's picture
CRF Health
08/02/2018 - 07:44
Ground-breaking study tests whether rejected livers can be made viable for transplantation
University of Birmingham's picture
University of B...
07/19/2018 - 19:04
Roches Tecentriq in combination with pemetrexed and platinum-based chemotherapy reduced the risk of disease worsening or death in the initial treatment of people with advanced lung cancer
Rocheusa's picture
Rocheusa
07/18/2018 - 07:56
Genentechs TECENTRIQ in Combination With Pemetrexed and Platinum-Based Chemotherapy Reduced the Risk of Disease Worsening or Death in the Initial Treatment of People With Advanced Lung Cancer
Genentech's picture
Genentech
07/10/2018 - 15:50
Kamada Receives Positive Scientific Advice from European Medicines Agency on a New Phase 3 Study Design for Inhaled AAT
Kamada's picture
Kamada
06/24/2018 - 21:21
Roches TECENTRIQ in combination with chemotherapy helped people with previously-untreated extensive-stage small cell lung cancer live significantly longer compared to chemotherapy
Rocheusa's picture
Rocheusa
06/24/2018 - 18:21
Genentechs TECENTRIQ in Combination with Chemotherapy Helped People with Previously-Untreated Extensive-Stage Small Cell Lung Cancer Live Significantly Longer Compared to Chemotherapy
Genentech's picture
Genentech
06/24/2018 - 01:37
Results further characterize the safety and effectiveness of INVOKANA
Johnson and Johnson's picture
Johnson and Johnson
06/19/2018 - 16:37
TransPerfect Life Sciences to Lead Collaboration Workshop and Release New Trial Interactive E-Clinical Technology at DIA 2018
TransPerfect's picture
TransPerfect
06/19/2018 - 14:57
Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
Grifols's picture
Grifols
06/02/2018 - 12:36
Phase III IMpower131 study showed Tecentriq(atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death for people with advanced squamous non-small cell lung cancer
Rocheusa's picture
Rocheusa
06/02/2018 - 12:17
Phase III IMpower131 Study Showed Genentechs TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin And ABRAXANE) Reduced the Risk of Disease Worsening or Death for People With Advanced Squamous Non-Small Cell Lung Cancer
Genentech's picture
Genentech
05/29/2018 - 11:48
Democratic Republic of Congo: MSF starts Ebola vaccination targeting remote communities
MSF's picture
MSF
05/27/2018 - 21:36
MSF starts Ebola vaccination targeting remote communities
MSF's picture
MSF
05/20/2018 - 22:43
Roches Hemlibra reduced treated bleeds by 96 percent compared to no prophylaxis in phase III HAVEN 3 study in haemophilia A without factor VIII inhibitors
Rocheusa's picture
Rocheusa
05/13/2018 - 22:35
Roche to present new phase III data for Hemlibra in people with haemophilia A at the World Federation of Hemophilia 2018 World Congress
Rocheusa's picture
Rocheusa
05/12/2018 - 20:52
Genentech to Present New Phase III Data for HEMLIBRA (emicizumab-kxwh) in People With Hemophilia A at the World Federation of Hemophilia 2018 World Congress
Genentech's picture
Genentech
04/24/2018 - 12:08
New England Journal of Medicine Published Open-label Study Showing Brineura (cerliponase alfa) Reduced the Rate of Clinical Decline of Children with CLN2 Disease, a Form of Batten Disease
BioMarin's picture
BioMarin
04/23/2018 - 22:48
Kamada Received Feedback from FDA on Proposed Phase 3 Protocol for Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease
Kamada's picture
Kamada
03/26/2018 - 05:23
Phase III IMpower150 study showed Roches TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus carboplatin and paclitaxel helped people with advanced lung cancer live longer compared to Avastin plus carboplatin and paclitaxel
Rocheusa's picture
Rocheusa
03/24/2018 - 23:32
Phase III IMpower150 Study Showed Genentechs TECENTRIQ (Atezolizumab) and Avastin (Bevacizumab) Plus Carboplatin and Paclitaxel Helped People With Advanced Lung Cancer Live Longer Compared to Avastin Plus Carboplatin and Paclitaxel
Genentech's picture
Genentech
12/29/2017 - 15:05
CEL-SCI REPORTS FISCAL 2017 FINANCIAL RESULTS AND CLINICAL & CORPORATE DEVELOPMENTS
Cel-Sci's picture
Cel-Sci
12/11/2017 - 12:48
CEL-SCI REACHES FULL ENROLLMENT IN PIVOTAL PHASE 3 HEAD AND NECK CANCER STUDY
Cel-Sci's picture
Cel-Sci
12/09/2017 - 11:22
Genentechs Hemlibra (emicizumab-kxwh) Continued to Substantially Reduce Bleeds in People with Hemophilia A with Inhibitors
Genentech's picture
Genentech
12/09/2017 - 08:24
BioMarin Provides 1.5 years of Clinical Data for Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A at 59th American Society of Hematology (ASH) Annual Meeting Concurrent with NEJM Publication
BioMarin's picture
BioMarin
12/09/2017 - 06:14
Roches Hemlibra continued to substantially reduce bleeds in people with haemophilia A with inhibitors
Rocheusa's picture
Rocheusa
12/06/2017 - 21:46
Roches Hemlibra every four weeks controlled bleeds in phase III study in haemophilia A
Rocheusa's picture
Rocheusa
12/06/2017 - 03:04
Genentechs HEMLIBRA (emicizumab-kxwh) Every Four Weeks Controlled Bleeds in Phase III Study in Hemophilia A
Genentech's picture
Genentech
11/13/2017 - 12:13
CEL-SCI ANNOUNCES UPDATE ON ARBITRATION AGAINST FORMER CLINICAL RESEARCH ORGANIZATION
Cel-Sci's picture
Cel-Sci
10/10/2017 - 12:59
Six-year Efficacy Data for GARDASIL 9 Presented at EUROGIN 2017 Congress
Merck's picture
Merck
08/28/2017 - 05:49
Bristol-Myers Squibb and Pfizer Present Investigational Eliquis (apixaban) Data for Patients with Non-Valvular Atrial Fibrillation (NVAF) Undergoing Cardioversion
Pfizer's picture
Pfizer
08/02/2017 - 13:11
BioMarin Announces Plans to Progress Both the 6e13vg/kg and 4e13 vg/kg Doses of BMN 270, its Investigational Gene Therapy for Hemophilia A, into Phase 3 Studies
BioMarin's picture
BioMarin
07/20/2017 - 08:32
Kamada Submits Proposed Phase 3 Protocol to FDA for Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease
Kamada's picture
Kamada
07/20/2017 - 08:26
How do eClincal solutions Increase Clinical Trial Efficiency?
PAREXEL's picture
PAREXEL
06/05/2017 - 11:16
Celldex Presents Promising Overall Survival Data from Phase 2 Study of Single-agent Glembatumumab Vedotin in Patients with Checkpoint-Refractory Metastatic Melanoma
Celldex's picture
Celldex
06/05/2017 - 06:20
CEL-SCI SUBMITS FDA RESPONSE FOR ITS PHASE 3 HEAD AND NECK CANCER TRIAL
Cel-Sci's picture
Cel-Sci
05/31/2017 - 08:41
MEI Pharma Announces Pre-Specified Response Rate Exceeded in Dose-Escalation Study of ME-401 in Chronic Lymphocytic Leukemia and Follicular Lymphoma
MEI Pharma's picture
MEI Pharma
05/09/2017 - 09:16
Cerus Announces Exercise of Additional BARDA Contract Options Totaling $46.6 million to Support INTERCEPT Red Blood Cell System Development
Cerus's picture
Cerus
03/14/2017 - 10:20
Study: Current tests for predicting spontaneous preterm births, not accurate
RTI International's picture
RTI International
11/07/2016 - 11:12
Testing of investigational inactivated Zika vaccine in humans begins
NIH's picture
NIH
10/17/2016 - 07:03
Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs
Teva Pharmaceutical's picture
Teva Pharmaceutical
10/10/2016 - 08:14
Peregrine Pharmaceuticals Reports Top-Line and Initial Biomarker Data from Phase III SUNRISE Trial of Bavituximab in Oral Presentation at European Society for Medical Oncology (ESMO) 2016 Congress
Peregrine's picture
Peregrine
09/21/2016 - 09:20
Peregrine Pharmaceuticals Provides Update on Oral Presentation of Top-Line Data from Phase III SUNRISE Trial of Bavituximab at European Society for Medical Oncology (ESMO) 2016 Congress
Peregrine's picture
Peregrine
08/30/2016 - 01:30
ENSURE-AF Data Support the Efficacy and Safety Profile of Daiichi Sankyos Once-Daily LIXIANA in Patients with Atrial Fibrillation Undergoing Cardioversion
Daiichi Sankyo's picture
Daiichi Sankyo
08/09/2016 - 02:19
ABLYNX REPORTS COMPELLING TOPLINE PHASE IIb STUDY RESULTS WITH ITS ANTI-IL-6R NANOBODY, VOBARILIZUMAB, IN RA PATIENTS, CONFIRMING ITS BEST-IN-CLASS POTENTIAL
FlandersBio's picture
FlandersBio
07/26/2016 - 19:42
Want to enroll in a clinical trial? NIH database is huge but lacks a few key details
Center for Genetics and Society's picture
Center for Gene...
07/26/2016 - 06:35
Eisai And Halozyme Initiate Phase 1b/2 Clinical Trial With First Patient Dosing Of Eribulin In Combination With PEGPH20
Halozyme's picture
Halozyme
06/28/2016 - 09:22
BioLineRx Announces Regulatory Submissions for Phase 2a Trial of BL-8040 in Combination with KEYTRUDA (pembrolizumab) for Treatment of Pancreatic Cancer
Biolinerx's picture
Biolinerx
06/21/2016 - 06:29
FDA Approves Use of the Procleix Zika Virus Assay from Hologic and Grifols to Screen the U.S. Blood Supply Under an IND Study Protocol
Grifols's picture
Grifols
01/11/2016 - 22:43
Peregrine Pharmaceuticals Provides Update on Planned Expansion of Bavituximab Clinical Program in Lung, Breast and Other Cancers
Peregrine's picture
Peregrine
01/11/2016 - 22:32
Halozyme Provides Key Program Updates, 2016 Financial Guidance At 34th Annual JP Morgan Healthcare Conference
Halozyme's picture
Halozyme